Intrinsiqs

Is Capricor Therapeutics, Inc. overvalued?

Capricor Therapeutics, Inc. (CAPR) — key valuation metrics and fundamentals.

No verdict
Price
$6.65
Fair value
Current P/E
Normal P/E
Market cap
$382.4M
Dividend yield
0.0%
Return on equity
-59.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CAPR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.